Product Images Nalbuphine Hydrochloride

This is information for Nalbuphine Hydrochloride Injection, presented in a 100 mg/10 mL multiple-dose vial. The injection contains nalbuphine hydrochloride, sodium citrate, citric acid, a mixture of preservatives, and sodium chloride. It is for intramuscular, subcutaneous, or intravenous use. The pH is adjusted to 3.0 to 4.5. The usual dosage information is found in the package insert. It should be stored at 25°C (77°F) with excursions permitted, protected from excessive light, and retained in the carton. Manufactured for Somerset Therapeutics, LLC in Somerset, NJ, with customer care contact information provided. Made in India with specific manufacturing code information included.*

This is a product description for Nalbuphine Hydrochloride Injection manufactured by Somerset Therapeutics, LLC in India. Each mL contains 10 mg nalbuphine hydrochloride, with sodium citrate, citric acid, methyl and propylparaben preservatives, and sodium chloride added. The solution is adjusted for tonicity and pH level. This medication is for intramuscular, subcutaneous, or intravenous use. The usual dosage details are provided in the package insert. It is recommended to store the vial at 25°C (77°F) with excursions permitted to 15°-30°C (59°-86°F). The product should be protected from excessive light.*

This is a description of a pharmaceutical product called Nalbuphine Hydrochloride Injection. Each mL contains 10 mg of nalbuphine hydrochloride along with other ingredients like sodium citrate and citric acid. The solution includes preservatives such as a mixture of methyl and propylparaben. It is adjusted to a pH of 3.0 to 4.5 with hydrochloric acid. The usual dosage information can be found in the package insert. The product should be stored at temperatures between 15°C to 30°C (59°F to 86°F) and protected from excessive light. It is a multiple-dose vial for intramuscular, subcutaneous, or intravenous use. For inquiries, contact Somerset Therapeutics, LLC.*

This text provides information about Nalbuphine Hydrochloride Injection, with a concentration of 200 mg/10 mL. It is intended for intramuscular, subcutaneous, or intravenous use. Each mL contains 20 mg of nalbuphine hydrochloride, along with other components as preservatives. The recommended storage temperature is 25°C (77°F) with excursions permitted to 15°-30°C (59°-86°F). The medication is manufactured for Somerset Therapeutics, LLC, and the customer care number is provided. It is made in India and has specific codes for identification and tracking purposes.*

This text contains information about a medication called Nalbuphine Hydrochloride Injection. It is a multiple-dose vial with a concentration of 200 mg/10 mL (20 mg/mL). The medication is intended for intramuscular, subcutaneous, or intravenous use. Each mL of the solution contains 20 mg of nalbuphine hydrochloride, along with other components. The typical dosage instructions and storage information are provided, along with contact information for Somerset Therapeutics, LLC.*

This is a description of Nalbuphine Hydrochloride Injection, a medication containing 20 mg nalbuphine hydrochloride per mL. The solution also comprises 0.94% sodium citrate dihydrate, 1.26% citric acid anhydrous, and a 9:1 mixture of methyl and propylparaben as preservatives. The pH is adjusted to 3.0 to 4.5 with hydrochloric acid if needed. Dosage guidance is available in the package insert. The medication should be stored at 25°C with excursions between 15°C to 30°C permitted. It should be protected from excessive light and should be kept in the carton until use. This product is made in India and distributed by Somerset Therapeutics, LLC based in Somerset, NJ.*